AbbVie Announces 20 Recipients of Migraine Career Catalyst Award™

Core Insights - AbbVie announced the recipients of its second annual Migraine Career Catalyst Award, providing each of the 20 winners with $2,500 to support their career and professional development goals [1][3][4] - The initiative aims to raise awareness about the impact of migraine in the workplace and to support individuals facing stigma and insufficient support due to their condition [2][3][5] Group 1: Award Details - The contest received entries from across the United States, showcasing a diverse group of professionals, including teachers, authors, and small business owners [3][5] - The award serves as a recognition of resilience and ambition among individuals whose careers have been disrupted by migraine [3][6] Group 2: Impact of Migraine - Migraine affects one in six people and is prevalent in nearly every workplace, yet awareness and understanding remain limited [2] - Presenteeism accounts for nearly 90% of migraine-related productivity loss, significantly impacting careers and overall well-being [5] Group 3: AbbVie's Commitment - AbbVie is the only company offering three prescription treatments that address the full spectrum of migraine, demonstrating its commitment to innovation and research in this area [4][5] - The Migraine Career Catalyst Award is part of AbbVie's broader commitment to understanding and addressing the challenges faced by individuals living with migraine in their professional lives [7]